BAO PHARMA-B(02659),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02659 BAO PHARMA-B

Not Yet Opened 11-13 16:08:15

10.440

-0.960

-8.42%

High11.750	Low10.290	Vol4.88M
Open11.390	D1 Closing11.400	Amplitude12.81%
Mkt Cap3.37B	Tradable Cap1.59B	Total Shares323.00M
T/O53.78M	T/O Rate3.21%	Tradable Shares152.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"BAO PHARMA-B","latestPrice":10.44,"timestamp":1794557295525,"preClose":11.4,"halted":0,"volume":4877900,"delay":0,"changeRate":-0.08421052631578954,"floatShares":152000000,"shares":323000000,"eps":-1.5981477820144676,"marketStatus":"Not Yet Opened","change":-0.96,"latestTime":"11-13 16:08:15","open":11.39,"high":11.75,"low":10.29,"amount":53779987,"amplitude":0.12807,"askPrice":10.49,"askSize":8800,"bidPrice":10.44,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-1.3905295833921762,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":0,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":11.4,"openAndCloseTimeList":[[1794533400000,1794542400000],[1794546000000,1794556800000]],"volumeRatio":0.8604485431268505,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02659/wiki","defaultTab":"wiki","newsList":[{"id":"2682300043","title":"Insiders In Shanghai Bao Pharmaceuticals Still Down 37% On CN¥7.37m Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2682300043","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682300043?lang=en_us&edition=fundamental","pubTime":"2026-11-10 07:29","pubTimestamp":1794266995,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 9, 2026","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2659/shanghai-bao-pharmaceuticals-shares/news/insiders-in-shanghai-bao-pharmaceuticals-still-down-37-on-cn","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2659/shanghai-bao-pharmaceuticals-shares/news/insiders-in-shanghai-bao-pharmaceuticals-still-down-37-on-cn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116870127","title":"Hong Kong Stock Move: BAO PHARMA-B (02659) Rises Over 7% as BJ045 Injection IND Recently Approved, Chairman's Frequent Share Buybacks Signal Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1116870127","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116870127?lang=en_us&edition=fundamental","pubTime":"2026-11-05 09:42","pubTimestamp":1793842945,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, BAO PHARMA-B (02659) rose more than 7% today, up 5.02% as of press time to HK$8.475, with a turnover of HK$2.1587 million.On the news front, BAO PHARMA-B has seen a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","02659","BK4585","BK4588","VXUS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148684517","title":"Bao Pharma Posts October 2026 Monthly Return: No Change in Share Capital, Public Float Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=1148684517","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148684517?lang=en_us&edition=fundamental","pubTime":"2026-11-02 17:29","pubTimestamp":1793611790,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) has filed its Monthly Return for the period ended 31 October 2026, confirming stable capital structure and continued compliance with Hong Kong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158546972","title":"Chairman Liu Yanjun Raises Stake in BAO PHARMA-B with 263,300 Shares Bought Over Three Days for About HK$2.0243 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1158546972","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158546972?lang=en_us&edition=fundamental","pubTime":"2026-10-28 18:58","pubTimestamp":1793185095,"startTime":"0","endTime":"0","summary":"The Hong Kong Stock Exchange's latest data shows that on October 23, 26, and 27, Chairman Liu Yanjun acquired a combined 263,300 shares of BAO PHARMA-B (02659), with a total consideration of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165155980","title":"BAO PHARMA-B (02659) Shares Rise Nearly 6% as Chairman Liu Yanjun Increases Stake; IND Application for BJ045 Injection Approved","url":"https://stock-news.laohu8.com/highlight/detail?id=1165155980","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165155980?lang=en_us&edition=fundamental","pubTime":"2026-10-28 10:18","pubTimestamp":1793153894,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) rose nearly 6% during intraday trading, up 3.16% as of press time to HK$8.15, with a turnover of HK$2.9609 million.On the news front, the latest data from the Hong Kong Stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","02659","BK4585","BK4588","VXUS","IBBQ","BMED","MDTX","IBBJ","PSYK","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676667955","title":"Bao Pharma Gets China Nod for Trial of Autoimmune Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2676667955","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676667955?lang=en_us&edition=fundamental","pubTime":"2026-10-20 18:54","pubTimestamp":1792493690,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals'  investigational new drug application for a clinical trial of BJ045 for Injection was approved by China's National Medical Products Administration.The drug was developed for the potential treatment of moderate-to-severe autoimmune diseases in combination with IgG-degrading enzymes, a Tuesday bourse filing showed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676662230","title":"Shanghai Bao Pharmaceuticals Says IND for BJ045 for Injection was Approved by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2676662230","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676662230?lang=en_us&edition=fundamental","pubTime":"2026-10-20 18:40","pubTimestamp":1792492853,"startTime":"0","endTime":"0","summary":"Oct 20 (Reuters) - Shanghai Bao Pharmaceuticals Co Ltd <2659.HK>::*IND FOR BJ045 FOR INJECTION WAS APPROVED BY NMPA*Further company coverage: 2659.HK* ((Reuters.Briefs@thomsonreuters.com;))((Reuters I","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nRSD4j3srf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676748661","title":"Shanghai Bao Pharmaceuticals Co Ltd - Ind for Bj045 for Injection was Approved by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2676748661","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676748661?lang=en_us&edition=fundamental","pubTime":"2026-10-20 18:00","pubTimestamp":1792490454,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nFWN4660YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133954081","title":"Hong Kong Stock Movers: BAO PHARMA-B (02659) Surges Over 15% in Early Trading as Clinical Research and Commercialization of Innovative Pipeline Progress Smoothly","url":"https://stock-news.laohu8.com/highlight/detail?id=1133954081","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133954081?lang=en_us&edition=fundamental","pubTime":"2026-10-08 09:53","pubTimestamp":1791424411,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) jumped more than 15% in early trading. As of press time, the stock was up 8.10% at HK$12.55, with a turnover of HK$7.3847 million.On the news front, clinical research and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","KCAI","VXUS","BK4588","BK4585","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145986177","title":"Bao Pharma Cuts Outstanding H Shares by 0.57% via HK$14.34 Million September Buy-Back","url":"https://stock-news.laohu8.com/highlight/detail?id=1145986177","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145986177?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:11","pubTimestamp":1790932316,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma; HKEX: 02659) has filed its Monthly Return for the period ended 30 September 2026, detailing a further contraction of its H-share float through...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198122124","title":"Bao Pharma Interim 2026: Revenue Falls 76% but KJ017 Secures NMPA Approval; Cash Reserves at RMB 1.04 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1198122124","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198122124?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:26","pubTimestamp":1790159205,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma, 02659) released its 2026 interim report covering the six months to 30 June 2026. Financial performance   • Revenue declined 76.5% year-on-year to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Bao Pharma Interim 2026: Revenue Falls 76% but KJ017 Secures NMPA Approval; Cash Reserves at RMB 1.04 Billion","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123970597","title":"BAO PHARMA-B Surges Over 10% in Early Trading as Core Pipeline Advances in Clinical Studies and Commercial Rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=1123970597","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123970597?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:50","pubTimestamp":1789962626,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) surged more than 10% during intraday trading before paring gains, with shares last up 5.56% at HK$14.63 on turnover of HK$12.16 million.The first half of the year marks a pivotal...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133093859","title":"Bao Pharma Completes HK$1.37 Million Buyback, Treasury Shares Rise to 2.79 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1133093859","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133093859?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:03","pubTimestamp":1788861804,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) repurchased 85,800 H-shares on 08 September 2026 via on-market transactions, paying a total of HK$1.37 million at prices ranging from HK$15.81 to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124774824","title":"BAO PHARMA-B (02659) Allocates HK$1.9957 Million to Buy Back 124,900 Shares on September 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1124774824","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124774824?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:56","pubTimestamp":1788774976,"startTime":"0","endTime":"0","summary":"On September 7, 2026, BAO PHARMA-B (02659) executed a share repurchase, spending approximately HK$1.9957 million to buy back 124,900 of its own shares.The company disclosed that the buyback was...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665720313","title":"Shanghai Bao Pharma Files HKEX Next-Day Return Disclosing Share Buyback at HKD 15.98 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2665720313","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665720313?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:47","pubTimestamp":1788774430,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX next-day return disclosing share buyback at HKD 15.98 eachShanghai Bao Pharmaceuticals repurchased 124,900 H shares on Sept. 7, holding them as treasury shares; no share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL3t0J9w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159388329","title":"BAO PHARMA-B Repurchases 183,400 H-Shares for HKD 2.99 Million, Lifting Treasury Stock to 2.58 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1159388329","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159388329?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:22","pubTimestamp":1788517321,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (trading as BAO PHARMA-B) disclosed that it repurchased 183,400 H-shares on the Hong Kong Stock Exchange on 4 September 2026. The on-market transactions were...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158121017","title":"Bao Pharma-B Repurchases HK$3.99 Million in Shares, Treasury Stock Rises to 2.40 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1158121017","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158121017?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:22","pubTimestamp":1788438178,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma-B) disclosed a share buyback of 240,900 H-shares on 3 September 2026. The repurchase, executed on the Hong Kong Stock Exchange under the existing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871031","title":"Shanghai Bao Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 3.99 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871031","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871031?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:05","pubTimestamp":1788437130,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX next-day return disclosing share repurchase at HKD 3.99 millionShanghai Bao Pharmaceuticals repurchased 240,900 H shares on Sept. 3, 2026 for treasury.Paid HKD 16.15–HKD 17.12 a share; aggregate consideration HKD 3,991,416.Cancelled shares: 0.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Bao Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on September 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL7nJfvB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165605785","title":"BAO PHARMA-B (02659) Spends Approximately HK$3.99 Million on Share Buyback on September 3","url":"https://stock-news.laohu8.com/highlight/detail?id=1165605785","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165605785?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:04","pubTimestamp":1788437052,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on September 3, 2026, it expended roughly HK$3.9914 million to repurchase 240,900 of its own shares.This buyback activity reflects the company's ongoing capital management strategy, utilizing available funds to consolidate its equity base in the open market.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100111680","title":"Bao Pharma-B Completes HK$1.99 Million Share Buyback, Outstanding Shares Fall to 152.29 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1100111680","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100111680?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:21","pubTimestamp":1788258102,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma-B) disclosed that it repurchased 119,200 H-shares on 1 September 2026 via on-exchange transactions, paying an aggregate HK$1.99 million. The shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.baopharma.com","stockEarnings":[{"period":"1week","weight":0.1891},{"period":"1month","weight":0.0235},{"period":"3month","weight":-0.3822},{"period":"6month","weight":-0.5841},{"period":"1year","weight":-0.6042},{"period":"ytd","weight":-0.8654}],"compareEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":-0.0278},{"period":"3month","weight":-0.0589},{"period":"6month","weight":-0.0896},{"period":"1year","weight":-0.1269},{"period":"ytd","weight":-0.0778}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shanghai Bao Pharmaceuticals Co Ltd is a China-based company principally engaged in research and development of pharmaceutical products. The Company leverages synthetic biology technology to develop and deliver recombinant biologic drugs, targeting conditions with limited treatment options and complex manufacturing challenges. The Company focuses on four areas, including large-volume subcutaneous drug delivery, antibody-mediated autoimmune conditions, drugs in assisted reproduction and recombinant biologic products as transformative alternative to traditional biochemical production. The Company’s Core Products comprise SJ02 (Slonva), a long-acting recombinant human follicle-stimulating hormone carboxyl-terminal peptide fusion protein (FSH-CTP), KJ017, a recombinant human hyaluronidase, and KJ103, an innovative recombinant immunoglobulin G (IgG)-degrading enzyme.","exchange":"SEHK","name":"BAO PHARMA-B","nameEN":"BAO PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BAO PHARMA-B(02659),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BAO PHARMA-B(02659) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BAO PHARMA-B,02659,BAO PHARMA-B股票,BAO PHARMA-B股票老虎,BAO PHARMA-B股票老虎国际,BAO PHARMA-B行情,BAO PHARMA-B股票行情,BAO PHARMA-B股价,BAO PHARMA-B股市,BAO PHARMA-B股票价格,BAO PHARMA-B股票交易,BAO PHARMA-B股票购买,BAO PHARMA-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BAO PHARMA-B(02659),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BAO PHARMA-B(02659) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}